The data indicates that antibacterial medicine sales in South Korea, measured as a percentage of total sales, are forecasted to decline steadily from 2024 to 2028. In 2023, this value stood at 3.5%. The year-on-year variation reveals a consistent decrease of approximately 9% annually over the past two years. The Compound Annual Growth Rate (CAGR) over the last five years, from 2023 to 2028, is projected to be around -7.6%, indicating an average annual reduction in sales proportions.
Future trends to watch for include the impact of new regulations on antibiotic use, shifts in prescribing practices, and advancements in alternative treatments for bacterial infections. Additionally, increased public awareness and preventive measures could further influence the decline in antibacterial medicine sales.
